Genoray Co. Ltd (122310) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.057x

Based on the latest financial reports, Genoray Co. Ltd (122310) has a cash flow conversion efficiency ratio of 0.057x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.78 Billion ≈ $3.24 Million USD) by net assets (₩83.75 Billion ≈ $56.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Genoray Co. Ltd (122310) defensive interval to measure how many days the company can operate on defensive assets alone.

Genoray Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Genoray Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Genoray Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Genoray Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Fine Metal Technologies Public Company Limited BK:FMT	0.224x
Progressive Planet Solutions Inc V:PLAN	0.088x
Tayih Lun An Co Ltd TWO:8107	0.010x
Tondo Smart Ltd TA:TNDO	-0.341x
Imugene Ltd AU:IMU	-0.620x
Wulff-Yhtiot Oy HE:WUF1V	0.164x
Eduspec Holdings Bhd KLSE:0107	-0.052x
Chariot Oil & Gas Limited F:C62	-0.033x

Annual Cash Flow Conversion Efficiency for Genoray Co. Ltd (2015–2025)

The table below shows the annual cash flow conversion efficiency of Genoray Co. Ltd from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see 122310 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩83.75 Billion ≈ $56.76 Million	₩5.26 Billion ≈ $3.56 Million	0.063x	-59.38%
2024-12-31	₩85.89 Billion ≈ $58.21 Million	₩13.27 Billion ≈ $9.00 Million	0.155x	+315.37%
2023-12-31	₩95.53 Billion ≈ $64.74 Million	₩3.55 Billion ≈ $2.41 Million	0.037x	-77.94%
2022-12-31	₩87.96 Billion ≈ $59.61 Million	₩14.84 Billion ≈ $10.05 Million	0.169x	-13.58%
2021-12-31	₩78.82 Billion ≈ $53.41 Million	₩15.38 Billion ≈ $10.43 Million	0.195x	+52.63%
2020-12-31	₩66.53 Billion ≈ $45.08 Million	₩8.51 Billion ≈ $5.77 Million	0.128x	-28.49%
2019-12-31	₩59.59 Billion ≈ $40.38 Million	₩10.65 Billion ≈ $7.22 Million	0.179x	+16.67%
2018-12-31	₩44.97 Billion ≈ $30.48 Million	₩6.89 Billion ≈ $4.67 Million	0.153x	-16.72%
2017-12-31	₩24.30 Billion ≈ $16.47 Million	₩4.47 Billion ≈ $3.03 Million	0.184x	-21.57%
2016-12-31	₩14.80 Billion ≈ $10.03 Million	₩3.47 Billion ≈ $2.35 Million	0.235x	+26.88%
2015-12-31	₩11.35 Billion ≈ $7.69 Million	₩2.10 Billion ≈ $1.42 Million	0.185x	--

About Genoray Co. Ltd

KQ:122310 Korea Diagnostics & Research

Market Cap

$28.57 Million

₩42.15 Billion KRW

Market Cap Rank

#23981 Global

#1654 in Korea

Share Price

₩3470.00

Change (1 day)

-4.93%

52-Week Range

₩3435.00 - ₩5880.00

All Time High

₩11740.92